1. Home
  2. CGEN vs SRI Comparison

CGEN vs SRI Comparison

Compare CGEN & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • SRI
  • Stock Information
  • Founded
  • CGEN 1993
  • SRI 1965
  • Country
  • CGEN Israel
  • SRI United States
  • Employees
  • CGEN N/A
  • SRI N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • SRI Auto Parts:O.E.M.
  • Sector
  • CGEN Health Care
  • SRI Consumer Discretionary
  • Exchange
  • CGEN Nasdaq
  • SRI Nasdaq
  • Market Cap
  • CGEN 167.4M
  • SRI 157.3M
  • IPO Year
  • CGEN 2000
  • SRI 1997
  • Fundamental
  • Price
  • CGEN $1.64
  • SRI $6.07
  • Analyst Decision
  • CGEN
  • SRI Buy
  • Analyst Count
  • CGEN 0
  • SRI 2
  • Target Price
  • CGEN N/A
  • SRI $16.00
  • AVG Volume (30 Days)
  • CGEN 264.8K
  • SRI 216.2K
  • Earning Date
  • CGEN 08-05-2025
  • SRI 07-30-2025
  • Dividend Yield
  • CGEN N/A
  • SRI N/A
  • EPS Growth
  • CGEN N/A
  • SRI N/A
  • EPS
  • CGEN N/A
  • SRI N/A
  • Revenue
  • CGEN $27,589,000.00
  • SRI $887,028,000.00
  • Revenue This Year
  • CGEN N/A
  • SRI N/A
  • Revenue Next Year
  • CGEN $173.80
  • SRI $10.18
  • P/E Ratio
  • CGEN N/A
  • SRI N/A
  • Revenue Growth
  • CGEN N/A
  • SRI N/A
  • 52 Week Low
  • CGEN $1.13
  • SRI $3.54
  • 52 Week High
  • CGEN $2.66
  • SRI $18.40
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 54.29
  • SRI 65.36
  • Support Level
  • CGEN $1.65
  • SRI $5.65
  • Resistance Level
  • CGEN $1.83
  • SRI $6.50
  • Average True Range (ATR)
  • CGEN 0.10
  • SRI 0.32
  • MACD
  • CGEN -0.01
  • SRI 0.04
  • Stochastic Oscillator
  • CGEN 47.50
  • SRI 84.28

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

Share on Social Networks: